Global Health Limited

Symbol: MEDANTA.NS

NSE

1407

INR

Market price today

  • 83.0259

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 377.79B

    MRK Cap

  • 0.00%

    DIV Yield

Global Health Limited (MEDANTA-NS) Financial Statements

On the chart you can see the default numbers in dynamics for Global Health Limited (MEDANTA.NS). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Global Health Limited, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM20222021202020192018

balance-sheet.row.cash-and-short-term-investments

013107.85118.12893
2501.2
2664.5

balance-sheet.row.short-term-investments

05435.43923.82198.3
1025.5
2060

balance-sheet.row.net-receivables

019422423.81655
1835.4
1910.7

balance-sheet.row.inventory

0603.7533.9397.6
385.2
248.9

balance-sheet.row.other-current-assets

0141.341.51730.7
42.9
61.6

balance-sheet.row.total-current-assets

015794.98117.25021.3
4786
4885.7

balance-sheet.row.property-plant-equipment-net

02371922088.520722.4
20763.5
18701.9

balance-sheet.row.goodwill

0000
0
0

balance-sheet.row.intangible-assets

051.762.772.5
84.8
13.7

balance-sheet.row.goodwill-and-intangible-assets

051.762.772.5
84.8
13.7

balance-sheet.row.long-term-investments

0-5005.5-3818.9-2009.8
-787.1
89

balance-sheet.row.tax-assets

0257.1277.9257.4
465.6
447.7

balance-sheet.row.other-non-current-assets

06342.64727.82877.2
1350
606.2

balance-sheet.row.total-non-current-assets

025364.823337.921919.7
21876.9
19858.5

balance-sheet.row.other-assets

0000
0
0

balance-sheet.row.total-assets

041159.631455.226941
26662.9
24744.3

balance-sheet.row.account-payables

01946.91343.31315.5
1307.4
1264.6

balance-sheet.row.short-term-debt

01393.61055.91029.5
531
416.2

balance-sheet.row.tax-payables

0000
0
0

balance-sheet.row.long-term-debt-total

09825.910033.38284.2
8758
5032.2

Deferred Revenue Non Current

0669.7218.7363.4
390.8
2421

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-

balance-sheet.row.other-current-liab

0983.523.714.1
10.7
1116.5

balance-sheet.row.total-non-current-liabilities

01115211100.39071
9590.9
8477.1

balance-sheet.row.other-liabilities

0000
0
0

balance-sheet.row.capital-lease-obligations

02797.32710.62867.8
3069.7
2421

balance-sheet.row.total-liab

016877.615295.113117.6
13167.5
11435.4

balance-sheet.row.preferred-stock

000325
325
325

balance-sheet.row.common-stock

0536.4506.4820.9
818.5
491.3

balance-sheet.row.retained-earnings

012837.99529.67689.8
7373.2
6930.6

balance-sheet.row.accumulated-other-comprehensive-income-loss

0237.3274.5442.5
603.6
656.1

balance-sheet.row.other-total-stockholders-equity

010670.55849.64545.2
4375.1
4551.9

balance-sheet.row.total-stockholders-equity

024282.116160.113823.4
13495.4
12955

balance-sheet.row.total-liabilities-and-stockholders-equity

041159.631455.226941
26662.9
24744.3

balance-sheet.row.minority-interest

0000
0
0

balance-sheet.row.total-equity

024282.116160.113823.4
13495.4
12955

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-

Total Investments

0429.9104.9188.6
238.4
2149

balance-sheet.row.total-debt

011219.511089.39313.8
9289
7869.4

balance-sheet.row.net-debt

03547.19894.98619.1
7813.3
7264.9

Cash Flow Statement

The financial landscape of Global Health Limited has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM20222021202020192018

cash-flows.row.net-income

04492.92805.6324.6
638.9
513

cash-flows.row.depreciation-and-amortization

01499.11297.11232.1
1150.4
1016

cash-flows.row.deferred-income-tax

0-7.5-874.5131.7
-312
0

cash-flows.row.stock-based-compensation

07.517.437.9
95.7
0

cash-flows.row.change-in-working-capital

01028.2-667.7365.9
20.7
28.7

cash-flows.row.account-receivables

0-214.6-495.6102.9
48
-303.7

cash-flows.row.inventory

0-69.8-136.3-12.4
-152.3
-5.6

cash-flows.row.account-payables

0603.627.88.1
42.8
202

cash-flows.row.other-working-capital

0709-63.5267.4
82.2
136.1

cash-flows.row.other-non-cash-items

0-582.6534.7325.4
157
-14.1

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-2359.9-2744.8-1457.4
-1882.7
-2996.9

cash-flows.row.acquisitions-net

0813.838
5.3
10.5

cash-flows.row.purchases-of-investments

0-1416.1-1725.4-1172.8
-222.5
0

cash-flows.row.sales-maturities-of-investments

0-883.750.4
1034.5
314.9

cash-flows.row.other-investing-activites

0352.5163.8150.3
194.7
0

cash-flows.row.net-cash-used-for-investing-activites

0-3423.4-4208.9-2391.5
-870.7
-2671.6

cash-flows.row.debt-repayment

0-666.5-198.9-30.2
-183.2
-1642.7

cash-flows.row.common-stock-issued

04785.5379.52.4
2.1
6.4

cash-flows.row.common-stock-repurchased

0000
0
0

cash-flows.row.dividends-paid

0000
0
0

cash-flows.row.other-financing-activites

0-662.61415.2-779.4
172.3
2902.5

cash-flows.row.net-cash-used-provided-by-financing-activities

03456.41595.9-807.2
-8.8
1266.2

cash-flows.row.effect-of-forex-changes-on-cash

0000
0
0

cash-flows.row.net-change-in-cash

06478.1499.7-781
871.2
138.3

cash-flows.row.cash-at-end-of-period

07672.41194.3694.7
1475.7
604.5

cash-flows.row.cash-at-beginning-of-period

01194.3694.71475.7
604.5
466.3

cash-flows.row.operating-cash-flow

06445.23112.62417.7
1750.7
1543.7

cash-flows.row.capital-expenditure

0-2359.9-2744.8-1457.4
-1882.7
-2996.9

cash-flows.row.free-cash-flow

04085.3367.9960.3
-132
-1453.2

Income Statement Row

Global Health Limited's revenue saw a change of NaN% compared with the previous period. The gross profit of MEDANTA.NS is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM20222021202020192018

income-statement-row.row.total-revenue

026942.521559.714306.1
14824.4
14411.3

income-statement-row.row.cost-of-revenue

06252.85429.33485.6
3248.3
10431.6

income-statement-row.row.gross-profit

020689.616130.410820.6
11576.1
3979.7

income-statement-row.row.gross-profit-ratio

0000
0
0

income-statement-row.row.research-development

0---
-
-

income-statement-row.row.selling-general-administrative

0---
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-

income-statement-row.row.other-expenses

0649.1122.480
163.9
29

income-statement-row.row.operating-expenses

015990.512730.59893.6
10606.6
3255.4

income-statement-row.row.cost-and-expenses

022243.318159.813379.2
13854.9
13687

income-statement-row.row.interest-income

0346.2167.2177.6
196.4
185.9

income-statement-row.row.interest-expense

0779.2789.5671
509.9
716

income-statement-row.row.selling-and-marketing-expenses

0---
-
-

income-statement-row.row.total-other-income-expensenet

0-855.4-594.3-602.3
-621.8
108.3

income-statement-row.row.ebitda-ratio-caps

0---
-
-

income-statement-row.row.other-operating-expenses

0649.1122.480
163.9
29

income-statement-row.row.total-operating-expenses

0-855.4-594.3-602.3
-621.8
108.3

income-statement-row.row.interest-expense

0779.2789.5671
509.9
716

income-statement-row.row.depreciation-and-amortization

01499.11297.11232.1
1150.4
1016

income-statement-row.row.ebitda-caps

0---
-
-

income-statement-row.row.operating-income

05348.33399.9927
1260.4
724.3

income-statement-row.row.income-before-tax

04492.92805.6324.6
638.7
832.7

income-statement-row.row.income-tax-expense

01232.1843.636.6
275.4
319.4

income-statement-row.row.net-income

03260.81962288.1
363.3
513

Frequently Asked Question

What is Global Health Limited (MEDANTA.NS) total assets?

Global Health Limited (MEDANTA.NS) total assets is 41159640000.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.768.

What is company free cash flow?

The free cash flow is 12.311.

What is enterprise net profit margin?

The net profit margin is 0.143.

What is firm total revenue?

The total revenue is 0.226.

What is Global Health Limited (MEDANTA.NS) net profit (net income)?

The net profit (net income) is 3260793000.000.

What is firm total debt?

The total debt is 11219519000.000.

What is operating expences number?

The operating expences are 15990499000.000.

What is company cash figure?

Enretprise cash is 0.000.